Differential in vitro inhibition studies of some cerium vanadate derivatives on xanthine oxidase

7Citations
Citations of this article
12Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

In this preliminary study, a new series of some cerium vanadate derivatives have been investigated as new type of inhibitors of xanthine oxidase (XO; E.C 1.17.3.2). XO is a superoxide-producing enzyme found normally in serum and the lungs, and its activity is concerned with several important health problems such as gout, severe liver damage, vascular dysfunction and injury, oxidative eye injury and renal failure. In this study, we present a critical overview of the effects of these novel type agents on XO with comparing the efficacy and safety profiles of allopurinol, the efficient classical inhibitor of XO.

Cite

CITATION STYLE

APA

Kaya, M. O., Kaya, Y., Çelik, G., Kurtuluş, F., Arslan, O., & Guler, O. O. (2015). Differential in vitro inhibition studies of some cerium vanadate derivatives on xanthine oxidase. Journal of Enzyme Inhibition and Medicinal Chemistry, 30(2), 286–289. https://doi.org/10.3109/14756366.2014.920837

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free